What is the market doing?
What the tape says about BCAX
Bicara Therapeutics Inc. is +142% over the past year while the S&P 500 is +23%: 120 points ahead of the market.
+142%
1-year return · S&P 500 +23%
- vs 200-day average
- +24%
vs 200-day average · a clear uptrend
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- −14%
Below its 52-week high
Details›
- Last close2026-08-26
- $24.70
- 1 monthS&P 500 +3.7%
- −11%
- 1 yearS&P 500 +23%
- +142%
- vs 50-day average$24.65
- +0.19%
- 52-week high
- $28.86
- 52-week low
- $9.99
- Annualised volatility
- 76%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $4.8M
| Year | Return |
|---|---|
| 2026 (year to date) | +47% |
| 2025 | −3.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #23 of 145 by Smart Score